TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
Key facts
- Who runs it
- Washington State University
- Where
- Portland, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Starts
- 1 Jun 2027
- Expected to end
- 1 Oct 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- TMS Low-Dose
- TMS High-Dose
- Record updated
- 29 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- 18+ years old
- Enrolled in the Intensive Outpatient Program at Another Chance Drug \& Alcohol Rehab Center of Portland, Portland, OR
- Diagnosed with Opioid Use Disorder
- Diagnosed with Alcohol Use Disorder
Who cannot take part
- Currently taking prescription benzodiazepines or anti-convulsive medications
- History of seizure disorder diagnosis
- History of Schizophrenia, Bipolar Disorder, Mania
- Children <18 years old
- Pregnant
- Non-English speaking
- In active alcohol or opioid withdrawal
Where in United States
- Another Chance Drug & Alcohol Rehab Center of PortlandPortland, United StatesContact: John Morgan, CADC II, QMHATaking people
About the trial
What the trial wants to find out
The study aims to explore the potential of Transcranial Magnetic Stimulation (TMS), particularly Theta Burst Stimulation (TBS), as an adjunctive treatment to enhance recovery outcomes (consumption and craving; withdrawal symptoms; mental, physical, sleep, and cognitive health; engagement with therapy, etc.) in individuals with Opioid Use Disorder (OUD) and individuals with Alcohol Use Disorder (AUD). This project will be completed in partnership with Another Chance Rehab (Portland): Portland's top addiction treatment program offering evidence-based treatment programs for a range of substance use disorders. Another Chance Rehab will serve as the project site for this work.
The 3 groups in the trial
- Treatment As UsualNo study treatment, for comparison
Study participants in this arm will engage in intensive outpatient alcohol and addiction treatment provided as it usually is for all patients in this program.
- 3-Minute TMSExisting treatment, for comparison
TAU + 3-minute TMS: Participants complete TAU as described above, with one 3-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).
Treatment: TMS Low-Dose
- 9-Minute TMSExisting treatment, for comparison
TAU + 9-minute TMS: Participants complete TAU as described above, with one 9-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).
Treatment: TMS High-Dose
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcranial Magnetic Stimulation (TMS) to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
- Record updated
- 29 May 2026